The Vall d´Hebron Institute of Oncology (VHIO)


Established in 2006, VHIO is a leading comprehensive cancer center of excellence where its researchers and physician-scientists adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.

Undertaking one of Spain´s most dynamic cancer research programs and recognized as a leading reference in drug discovery from concept to the clinic (phase I-II clinical trials),  VHIO is dedicated to delivering on the promise of ´precision´medicine in oncology – turning cancer discovery into more effective treatments and better practice for the care of patients.

back to top



ICREA is a foundation supported by the Catalan Government established to strengthen the research system in Catalunya, recruiting and retaining top researchers in the Catalan R&D system. They have an excellent track record in technology transfer and lab-to-market initiatives in general.

back to top



HealthEquity is a Spanish venture capital firm investing in early-stage companies in the healthcare sector, with a special focus on biotechnology and medical devices. Founded by the Barcelona Medical Association and the financial group Riva y Garcia, HealthEquity is looking for projects to bring successful innovative life science companies to the marketplace and to foster the Catalan and Spanish biotech ecosystem.

back to top